Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 190,765 $ 402,415
Accounts receivable, net 221,412 280,271
Inventories 149,718 157,646
Prepaid expenses and other assets 448,209 472,816
Total current assets 1,010,104 1,313,148
Property and equipment, net 16,810,650 16,433,292
Goodwill 135,764 98,134
Trade names, carrying value 500,525 500,525
Other long-term assets 1,512,768 1,147,891
Total assets 19,969,811 19,492,990
Current liabilities:    
Current portion of long-term debt 1,323,769 1,744,778
Accounts payable 171,106 174,338
Accrued expenses and other liabilities 1,180,026 1,058,919
Advance ticket sales 3,105,964 3,060,666
Total current liabilities 5,780,865 6,038,701
Long-term debt 11,776,721 12,314,147
Other long-term liabilities 986,786 839,335
Total liabilities 18,544,372 19,192,183
Commitments and contingencies (Note 13)
Shareholders' equity:    
Ordinary shares, $0.001 par value; 980,000,000 shares authorized; 439,861,281 shares issued and outstanding at December 31, 2024 and 425,546,570 shares issued and outstanding at December 31, 2023 440 425
Additional paid-in capital 7,921,918 7,708,957
Accumulated other comprehensive income (loss) (507,039) (508,438)
Accumulated deficit (5,989,880) (6,900,137)
Total shareholders' equity 1,425,439 300,807
Total liabilities and shareholders' equity $ 19,969,811 $ 19,492,990